Recently, the SIPO issued the Notice of the State Intellectual Property Office on Determining the New Batch of National Intellectual Property Demonstration Enterprises and Advantage Enterprises in 2023 and Passing Review. After the procedures of enterprise evaluation, local assessment, recommendation and confirmation, Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. has been recognized as one of the new batch of national intellectual property advantage enterprises in 2023 by virtue of its industry-leading R&D and innovation strength, complete intellectual property management system, and outstanding intellectual property management level.

What is a National Intellectual Property Advantage Enterprise

The "National Intellectual Property Advantage Enterprise" is one of the highest honors and evaluations granted by the state to enterprises with outstanding work in the creation, application, protection and management of intellectual property. It is mainly awarded to enterprises that are capable of undertaking major and key industrial development projects in the national and local key development areas, possess independent intellectual property rights capabilities, actively carry out intellectual property protection and application, establish comprehensive intellectual property management systems and mechanisms, and possess comprehensive intellectual property strength. The selection of "National Intellectual Property Advantage Enterprises" is the first national honor in the field of intellectual property rights since the company has been recognized as a "Sichuan Provincial Independent Intellectual Property Advantage Enterprise". This marks the authoritative recognition by the China National Intellectual Property Administration of Yuanda Shuyang's intellectual property management level and comprehensive strength, and demonstrates Yuanda Shuyang's unremitting pursuit of innovation and professionalism as a high-tech enterprise.

Non-stop Technological Innovation

Innovation is the first productive force leading development. As a high-quality international service provider of the whole product chain of blood products, Yuanda Shuyang has constructed a core patent group of innovative products, continuously enhanced the benefits and competitive advantages of intellectual property utilization, and strived to build the first square of intellectual property strong enterprises in the blood products industry. In recent years, Yuanda Shuyang has applied for more than 104 domestic and foreign patents, and has been granted nearly 50 patents, including 16 domestic patents for invention, 31 patents for utility model, 3 patents for design, and 3 patents authorized by PCT.

Meanwhile, Yuanda Shuyang also has actively practiced the integration of industry and education, and established a joint training base for the integration of industry and education in cooperation with Shanghai Jiao Tong University and Sichuan Blood Products Engineering and Technology Research Center, to carry out joint research on special topics around the industry's technological needs and chokepoints, and to cultivate high-level scientific and technological talents with strong practicality, openness, and professionalism.

In the future, Yuanda Shuyang will also take the recognition of National Intellectual Property Advantage Enterprise as an opportunity to deeply participate in the implementation of national Special Action Program for Patent Transformation and Application (2023-2025), give full play to the important supporting role of intellectual property rights in innovation-driven development, promote the high-quality development of the blood products industry, and vigorously support the construction of a strong intellectual property country.